2. Academic Validation
  3. Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir)

Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir)

  • Bioorg Med Chem Lett. 2001 Jun 4;11(11):1351-3. doi: 10.1016/s0960-894x(01)00243-8.
H L Sham 1,  D A Betebenner,  T Herrin,  G Kumar,  A Saldivar,  S Vasavanonda,  A Molla,  D J Kempf,  J J Plattner,  D W Norbeck
Affiliations

Affiliation

  • 1 Pharmaceutical Discovery, D47B, Building AP-10, Abbott Laboratories, Abbott Park, IL 60064-6101, USA. hing.l.sham@abbott.com
PMID: 11378352 DOI: 10.1016/s0960-894x(01)00243-8
Abstract

The HIV Protease Inhibitor ABT-378 (Lopinavir) is metabolized rapidly and extensively by CYP-3A4 catalyzed oxidation. Three of the major metabolites identified were synthesized and their Antiviral (HIV) activities determined.

Figures
Products